Better known to the public by brand names such as Ozempic, Wegovy, Trulicity, Rybelsus, Victoza, Saxenda, and Mounjaro, these glucose-lowering medications, which were initially approved for the treatment of patients with type 2 diabetes, have made headlines recently thanks to their demonstrated effectiveness at treating obesity and helping people with or without diabetes lose weight
As of 2025, public trackers report roughly 1,500 to 2,000 active cases nationwide
All of them work best when combined rather than used in isolation
If a brand focuses on holistic fitness, including strength training, semaglutide can be a valuable addition rather than a threat